Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Liver Failure

imatinib mesylate has been researched along with Liver Failure in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franke, RM; Sparreboom, A1
Csete, M; Heffron, T; Knowles, D; Lawrence, EC; Tapper, EB1
Akyurek, N; Benekli, M; Buyukberber, S; Coskun, U; Demirci, U; Karakan, T; Tonyali, O; Yildiz, R1
Bejarano, PA; Jeffers, LJ; Martinez, EJ; Mindikoglu, AL; Regev, A; Schiff, ER1
Schwetz, BA1

Other Studies

5 other study(ies) available for imatinib mesylate and Liver Failure

ArticleYear
Inhibition of imatinib transport by uremic toxins during renal failure.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-01, Volume: 26, Issue:25

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Benzamides; Biological Availability; Biological Transport; Humans; Imatinib Mesylate; Kidney Failure, Chronic; Liver Failure; Neoplasms; Organic Anion Transporters; Paclitaxel; Piperazines; Pyrimidines; Xenopus laevis

2008
Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.
    Transplantation proceedings, 2009, Volume: 41, Issue:5

    Topics: Antihypertensive Agents; Benzamides; Bosentan; Epoprostenol; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Imatinib Mesylate; Liver Failure; Liver Transplantation; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Treatment Outcome

2009
Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Acute Disease; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Liver; Liver Failure; Middle Aged; Peritoneal Neoplasms; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sunitinib

2010
Imatinib mesylate (gleevec) hepatotoxicity.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:2

    Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Antineoplastic Agents; Aspartate Aminotransferases; Benzamides; Bilirubin; Blood Cell Count; Erythrocyte Indices; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure; Male; Necrosis; Piperazines; Protein Kinase Inhibitors; Prothrombin Time; Pyrimidines; Time Factors

2007
From the Food and Drug Administration.
    JAMA, 2002, Mar-06, Volume: 287, Issue:9

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Arthritis, Psoriatic; Benzamides; Chemical and Drug Induced Liver Injury; Cyclohexanones; Enzyme Inhibitors; Etanercept; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunoglobulin G; Infant; Liver Failure; Nitrobenzoates; Orphan Drug Production; Piperazines; Pyrimidines; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Triazoles; Tyrosinemias; United States; United States Food and Drug Administration

2002